
ADvantage Therapeutics
ADvantage Therapeutics develops novel therapeutics to treat neurodegenerative conditions, with a major focus on Alzheimer’s Disease.
- 9
- Company
- Miami, FL, USUnited States
ADvantage Therapeutics develops novel therapeutics to treat neurodegenerative conditions, with a major focus on Alzheimer’s Disease. In one clinical trial, patients receiving AD04 as a control unexpectedly benefited from it.
Its investigation of AD04 identified a mechanism of action that eliminates lipid waste in the brain and reduces inflammation, contrasting with the dominant Alzheimer’s research focus on antibody therapies against amyloid‑beta peptide species that accumulate in patients’ brains.
Similar Companies

Therini Bio
therinibio.com

Allyx Therapeutics
allyxthera.com

Aztherapies
Advent Therapeutics

Libra Therapeutics

Inflammasome Therapeutics
inflam.com

Adcentrx Therapeutics
adcentrx.com

Halia Therapeutics
haliatx.com

Aliada Therapeutics
aliadatx.com

NeuroTherapia
neurotherapia.com
Adtech Pharma
adtechpharma.com

Prevail Therapeutics

Arkuda Therapeutics
arkudatx.com

Aprinoia Therapeutics
aprinoia.com

Adrx
adrxpharma.com

Guardian Therapeutics
Endlyz Therapeutics
endlyz.com

Cognito Therapeutics
cognitotx.com

Adipo Therapeutics

Gain Therapeutics
Quick Facts
Who are ADvantage Therapeutics' competitors?
Companies similar to ADvantage Therapeutics include Therini Bio, Allyx Therapeutics, Aztherapies and Advent Therapeutics.
When was ADvantage Therapeutics founded?
ADvantage Therapeutics was founded in 2021.
Where is ADvantage Therapeutics' headquarters located?
ADvantage Therapeutics' headquarters is located in Miami, FL, US.
When was ADvantage Therapeutics' last funding round?
ADvantage Therapeutics' most recent funding round was for $10.2M (USD) in July 2023.
How much disclosed funding has ADvantage Therapeutics raised?
As of Jul 12, 2023, ADvantage Therapeutics has disclosed funding of $15.2M (USD). Undisclosed round amounts are excluded.
How many employees does ADvantage Therapeutics have?
ADvantage Therapeutics has 9 employees as of Feb 5, 2024.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- Tags
- Also Known As
- ADvantage Therapeutics, Inc.
- Headquarters
- 195 NW 40th St
- Miami, FL, 33127
- US
- SEC CIK
- 0001869338
- EIN
- 86-3737093
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 13 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified